What are some of the newest drugs doctors use to combat colorectal cancer?
Recent studies have shown that patients who took the drug Avastin (Bevacizumab) with their standard chemotherapy treatment had a logner survival than those who did not take Avastin for their treatment of stage IV cancer. The same held true for the drug Erbitux (Cetuximab). Scientists are also working on new vaccines and monoclonal antibodies that may improve how patients’ immune systems respond to colorectal cancers. Monoclonal antibodies are a single type of antibody, that researchers make in large amounts in a lab, designed to bind to cancer cells wherever they are in the body for the purpose of helping to shrink tumours.
